Neuregulin-1 (NRG1) and its ErbB2/B4 receptors are encoded by candidate susceptibility genes for schizophrenia, yet the essential functions of NRG1 signaling in the CNS are still unclear. Using CRE/LOX technology, we have inactivated ErbB2/B4-mediated NRG1 signaling specifically in the CNS. In contrast to expectations, cell layers in the cerebral cortex, hippocampus, and cerebellum develop normally in the mutant mice. Instead, loss of ErbB2/B4 impairs dendritic spine maturation and perturbs interactions of postsynaptic scaffold proteins with glutamate receptors. Conversely, increased NRG1 levels promote spine maturation. ErbB2/B4-deficient mice show increased aggression and reduced prepulse inhibition. Treatment with the antipsychotic drug clozapine reverses the behavioral and spine defects. We conclude that ErbB2/B4-mediated NRG1 signaling modulates dendritic spine maturation, and that defects at glutamatergic synapses likely contribute to the behavioral abnormalities in ErbB2/ B4-deficient mice.cerebral cortex ͉ dendritic spines ͉ migration ͉ neuregulin ͉ schizophrenia N RG1 activates receptor tyrosine kinases consisting of dimers formed by ErbB2, ErbB3, and ErbB4. Both ErbB3 and ErbB4 bind NRG1, whereas ErbB2 and ErbB4 have intrinsic tyrosine kinase activity. Functional NRG1 receptors therefore consist of ErbB4 homodimers, or of heterodimers between ErbB2, ErbB3 and ErbB4 (1). NRG1 and its receptors are expressed in the CNS and the NRG1, ErbB2, and ErbB4 genes are candidate susceptibility genes for schizophrenia (1, 2). In the central nervous system (CNS), NRG1 is thought to regulate the differentiation of radial glia and neurons, myelination, neuronal migration and synaptic function (1). However, mice with targeted deletions of NRG1, ErbB2 and ErbB4 die during embryogenesis, whereas mice lacking ErbB3 die perinatally (3-6). Thus, our knowledge of NRG1-ErbB functions in the CNS has been derived from studies using cultured cells, dominantnegative ErbB receptors, and mice partially defective in NRG1 signaling (1). No animal model lacking all NRG1 signaling specifically in the CNS has been described. We have therefore engineered ErbB2/B4-CNSko mice that lack both ErbB2 and ErbB4 (the only ErbBs with intrinsic tyrosine kinase activity) in the CNS. Surprisingly, the mutant mice show no defects in brain morphology and in the layered structure of the cerebral cortex, hippocampus, and cerebellum. Instead, the maturation of dendritic spines is affected. ErbB2/B4-deficient mice also display behavioral abnormalities that have been associated with schizophrenia-like symptoms. Clozapine treatment reverses behavioral and spine defects, indicating that perturbation of glutamatergic synapses might contribute to the behavioral abnormalities. Interestingly, reduced spine density has been observed in the brain of schizophrenia patients (7), suggesting that defects in spine maturation may constitute a risk factor for the development of schizophrenia.
ResultsNormal Cortical Development and Glial-Guided Migration. To inactivate NR...